211 related articles for article (PubMed ID: 15299833)
1. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
[TBL] [Abstract][Full Text] [Related]
3. Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase.
Venkatarangan P; Hopfinger AJ
J Med Chem; 1999 Jun; 42(12):2169-79. PubMed ID: 10377222
[TBL] [Abstract][Full Text] [Related]
4. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic studies on two bioisosteric analogues, N-acetyl-beta-D-glucopyranosylamine and N-trifluoroacetyl-beta-D-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase.
Anagnostou E; Kosmopoulou MN; Chrysina ED; Leonidas DD; Hadjiloi T; Tiraidis C; Zographos SE; Györgydeák Z; Somsák L; Docsa T; Gergely P; Kolisis FN; Oikonomakos NG
Bioorg Med Chem; 2006 Jan; 14(1):181-9. PubMed ID: 16213146
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
Watson KA; Chrysina ED; Tsitsanou KE; Zographos SE; Archontis G; Fleet GW; Oikonomakos NG
Proteins; 2005 Dec; 61(4):966-83. PubMed ID: 16222658
[TBL] [Abstract][Full Text] [Related]
7. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
Mitchell EP; Withers SG; Ermert P; Vasella AT; Garman EF; Oikonomakos NG; Johnson LN
Biochemistry; 1996 Jun; 35(23):7341-55. PubMed ID: 8652510
[TBL] [Abstract][Full Text] [Related]
8. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
[TBL] [Abstract][Full Text] [Related]
9. Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.
Watson KA; Mitchell EP; Johnson LN; Son JC; Bichard CJ; Orchard MG; Fleet GW; Oikonomakos NG; Leonidas DD; Kontou M
Biochemistry; 1994 May; 33(19):5745-58. PubMed ID: 8180201
[TBL] [Abstract][Full Text] [Related]
10. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
[TBL] [Abstract][Full Text] [Related]
11. Binding of beta-D-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: kinetic and crystallographic studies.
Chrysina ED; Kosmopoulou MN; Kardakaris R; Bischler N; Leonidas DD; Kannan T; Loganathan D; Oikonomakos NG
Bioorg Med Chem; 2005 Feb; 13(3):765-72. PubMed ID: 15653344
[TBL] [Abstract][Full Text] [Related]
12. A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis.
Pastor M; Cruciani G; Watson KA
J Med Chem; 1997 Dec; 40(25):4089-102. PubMed ID: 9406599
[TBL] [Abstract][Full Text] [Related]
13. Crystallographic studies on N-azidoacetyl-beta-D-glucopyranosylamine, an inhibitor of glycogen phosphorylase: comparison with N-acetyl-beta-D-glucopyranosylamine.
Petsalakis EI; Chrysina ED; Tiraidis C; Hadjiloi T; Leonidas DD; Oikonomakos NG; Aich U; Varghese B; Loganathan D
Bioorg Med Chem; 2006 Aug; 14(15):5316-24. PubMed ID: 16616506
[TBL] [Abstract][Full Text] [Related]
14. The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies.
Oikonomakos NG; Zographos SE; Johnson LN; Papageorgiou AC; Acharya KR
J Mol Biol; 1995 Dec; 254(5):900-17. PubMed ID: 7500360
[TBL] [Abstract][Full Text] [Related]
15. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.
Johnson LN; Snape P; Martin JL; Acharya KR; Barford D; Oikonomakos NG
J Mol Biol; 1993 Jul; 232(1):253-67. PubMed ID: 8331662
[TBL] [Abstract][Full Text] [Related]
16. Glycogen phosphorylase inhibitors: a free energy perturbation analysis of glucopyranose spirohydantoin analogues.
Archontis G; Watson KA; Xie Q; Andreou G; Chrysina ED; Zographos SE; Oikonomakos NG; Karplus M
Proteins; 2005 Dec; 61(4):984-98. PubMed ID: 16245298
[TBL] [Abstract][Full Text] [Related]
17. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a ligand-receptor binding event using receptor-dependent four-dimensional quantitative structure-activity relationship analysis.
Pan D; Liu J; Senese C; Hopfinger AJ; Tseng Y
J Med Chem; 2004 Jun; 47(12):3075-88. PubMed ID: 15163189
[TBL] [Abstract][Full Text] [Related]
19. The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase.
Oikonomakos NG; Kontou M; Zographos SE; Tsitoura HS; Johnson LN; Watson KA; Mitchell EP; Fleet GW; Son JC; Bichard CJ
Eur J Drug Metab Pharmacokinet; 1994; 19(3):185-92. PubMed ID: 7867660
[TBL] [Abstract][Full Text] [Related]
20. Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.
Leonidas DD; Oikonomakos NG; Papageorgiou AC; Acharya KR; Barford D; Johnson LN
Protein Sci; 1992 Sep; 1(9):1112-22. PubMed ID: 1304390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
